March 27, 2018

Dr. Susan Blaney, deputy director of Texas Children’s Cancer and Hematology Centers, recently received a Director’s Service Award from the National Cancer Institute for her outstanding and dedicated service to the Institute and the Clinical Trials and Translational Research Advisory Committee from 2015 to 2017.

Blaney is the vice chair of the Children’s Oncology Group, the National Cancer Institute (NCI) supported clinical trials group and the world’s largest organization devoted exclusively to pediatric cancer research.

Blaney served as the co-director of the Developmental Therapeutics Program at Texas Children’s Cancer Center where she performs pre-clinical and clinical studies of new antineoplastic agents. A primary focus of her research is the development of new drugs for the treatment of central nervous system tumors in children with a particular emphasis on the development of new agents for intrathecal administration.

For more information about Dr. Susan Blaney, visit https://www.texaschildrens.org/find-a-doctor/susan-m-blaney-md.

February 20, 2018

On February 9, more than 350 guests joined event chairs Sidney Faust, Judi McGee, Elsie Eckert and Scott Basinger for the 10th annual Celebration of Champions fashion show and luncheon at the River Oaks Country Club.

The event featured a fashion show with pediatric cancer survivors from Texas Children’s Cancer Center walking the runway with this year’s Community Champions, a group of notable Houstonians who do so much to help children battling cancer and make the community a better place.

More than your typical fashion show, it was a “look at me now” moment for children who have seen some dark days early in their lives in their fight with cancer. View a gallery of photos from the event below.

In addition to showcasing the latest fashion trends from Saks Fifth Avenue and Dillard’s, the event also featured a special appearance by the honorary event chairs Jeff Bagwell and Mary Lou Retton. Bagwell and Retton kicked off the event with the lighting of the Torch of Hope and later took the runway alongside patient champions.

Since its inception, the event has raised more than $1.5 million for the Long Term Cancer Survivor Program at Texas Children’s Cancer Center, which monitors patients for delayed side effects and complications caused by previous cancer therapies. Not every pediatric cancer treatment center continues to care for its patients into adulthood however, caregivers at Texas Children’s Cancer Center recognize that health concerns for childhood cancer patients do not end when their cancer treatment is successfully completed.

The program currently has 25,000 long-term pediatric cancer survivors nationwide enrolled in Passport for Care®, an online resource guide developed at Texas Children’s and Baylor College of Medicine that provides individualized health care information to guide physicians’ care for late risks and effects from childhood cancer treatment. It has developed an international reputation as a leader in the field and has attracted a world-renowned faculty involved in local, national and international research that benefits today’s pediatric cancer patients and future survivors.

The event’s Community Champions included Jeff and Rachel Bagwell, Mary Lou Retton, Dr. David Poplack, Lisa McCoy, Linda and Mark Evans, Winell and Doug Herron, Kristy and Chris Bradshaw, Christie and Billy McCartney, Kathi and Bill Rovere, Tena and Tyson Faust, Hannah and Cal McNair, Penny and John Butler, Mary and John Eads, Diane and John Riley, Courtney and Christopher Sarofim. Among the event’s other medically-minded supporters were Flo Crady, Emily Crosswell, Bo Butler, Scott Butler, Megan Cushing, Bethany Hibbetts, Caroline Walter, Joanna and Brad Marks, Lisa and Mike O’Leary, Carmen and Butch Mach.

December 19, 2017

Sky High, a non-profit organization dedicated to eradicating pediatric cancer, made a generous donation of $725,000 to Texas Children’s Cancer and Hematology Centers during a Christmas Carnival the organization hosted on the 14th floor of Wallace Tower for cancer and hematology patients and their families.

“Days like today keep us doing what we do,” said Brittany Hebert, the founder and chief executive officer of Sky High, which raises funds by hosting a variety of events including concerts, golf tournaments and sporting clay tournaments. “We are happy to here and be able to help.”

Dr. ZoAnne Dreyer, an oncologist with the Cancer Center, said the money donated by Sky High will go toward developing a tumor biology lab and will undoubtedly play a significant role is helping research and treat childhood cancer.

“We are so appreciative of your generosity,” Dreyer told Hebert and her team of elves who helped secure the donation and who made the Christmas Carnival a hit with patients and families. “We are privileged to have a relationship with such a great organization.”

Texas Children’s Physician-In-Chief Dr. Mark W. Kline echoed Dreyer’s comments and said that he too is proud to be a part of Sky High, an organization dedicated to such a noble cause.

To learn more about Sky High, click here.

November 29, 2017

Information Services, the Cancer and Hematology Centers and Pharmacy recently partnered to successfully launch Epic Beacon, a new medical oncology module that gives physicians and other providers a better tool with which they can create personalized treatment plans and support care regimens based on standardized protocols. The outcome of such treatment plans and support care is a more efficient and effective way to follow each patient through outpatient doctor’s visits and inpatient hospital stays, easing the patient’s transition to lifetime, post-cancer care.

“This initiative has changed how we deliver care to some of our sickest patients,” said Cancer Center Director Dr. David Poplack. “With Beacon, we are able to provide more tailored treatment, more efficiently and at a decreased risk to our patients who receive some of the strongest medications.”

During the 18-month implementation process, about 600 treatment protocols were made electronic via Epic Beacon, which is fully integrated with Epic’s pharmacy and electronic Medication Administration Records (MAR) products, allowing oncologists to better track medications that have been dispensed and administered, including medications ordered outside of an oncology treatment plan.

In addition, Beacon, which is being used system wide where oncology patients receive chemotherapy, features decision support that can suggest protocols as well as dose-specific medication modifications based on chart data. It also tailors plans at the patient level, so medication orders can be created and queued up in advance of patient visits for cancer treatment.

“Using Beacon has been a culture change for the Cancer Center but well worth it,” said Julie McGuire, director of Enterprise Systems for Information Services. “It has taken real dedication from all teams involved as well as a tremendous amount of physician and nurse engagement.”

Dr. ZoAnn Dreyer, an oncologist with the Cancer Center, said Epic Beacon’s buildout and go-live process was smooth and seamless.

“Even Epic’s own representative was impressed, saying it was the best he has ever seen,” Dryer said. “And it’s worked well in clinic so far for sure!”

Other first impressions of Epic Beacon have been positive as well:

“I’ve never seen a project with as much dedicated physician support and I think that was a HUGE part of this project’s success!”
Drew Willert, Information Services

“The success of the go-live and Beacon’s functionality is a direct result of a multidisciplinary team that demonstrated resilience, excellence and commitment to the overall success of the project.”
Denise Tanner-Brown, Cancer and Hematology Centers

“I am so proud of what WE have done. I am so humbled by all of the outpouring of support from operational, Epic and IS leaders, as well as end users on the front lines.”
Dr. Marla Daves, Cancer and Hematology Centers

November 21, 2017

Hundreds of Texas Children’s supporters attended The Forum Luncheon in Houston on November 13. Hosted by The Development Department, the event focused on the success of the Texas Children’s Cancer Center and featured stories from two cancer survivors as well as an in-depth conversation between Cancer Center Director Dr. David Poplack and Fox 26 Morning News Co-Anchor Melissa Wilson.

Poplack’s conversation with Wilson illustrated how far the Cancer Center has come in helping children with cancer, growing from six faculty, 42 employees, one laboratory and less than $300,000 in grant funding when Poplack joined the center in 1993 to a center that now has 190 faculty, more than 900 employees, 46 laboratories and about $40 million a year in peer reviewed grant funding.

“We have become the largest and we believe the finest children’s cancer program in the country,” Poplack said. “Through our many research advances, our development of exciting, effective, new therapies and most recently through our burgeoning global program, we are having a far-reaching impact on the field.”

Poplack emphasized the need for children to be treated in children’s hospitals like Texas Children’s, which has expert multi-disciplinary teams equipped to tend to all aspects of a child’s care. As the largest pediatric cancer center in the U.S., we provide individualized, state-of-the-art medical treatment for patients with childhood cancer, he said.

“Treating children from more than 35 states and 26 countries, we aim to provide the most family-centered, advanced care available,” Poplack added. “In addition to continued excellence and leadership in treating all forms of pediatric cancer, we continue to expand and grow to better serve our patients.”

Poplack stressed that even with dramatic improvements in treating children with cancer – increasing the survival rate from 20 percent to 80 percent – the disease still is the leading cause of death from disease in children in the nation.

That’s why Texas Children’s Cancer Center is vigilant in its research efforts, especially in the areas of developmental therapeutics, precision oncology and cell therapy and immunotherapy.

“We are dedicated to developing effective treatments for the 20 percent of childhood cancers that are most difficult to treat,” he said. “We won’t quit until we find a cure, and even then, we will move forward to find better ways to help fulfill the long-term needs of childhood cancer survivors.”

November 14, 2017

For more than a decade, the Purple Songs Can Fly recording studio at Main Campus has offered a place for cancer patients and patients with blood disorders to express how they feel about their disease and the treatments they are undergoing to battle it. Siblings of such patients also are able to use the studio.

Thousands of songs have been written and produced in the colorful space sandwiched between clinic rooms on the 14th floor of the Texas Children’s Cancer and Hematology Centers. Now, a similar space is available to cancer and hematology patients cared for at Texas Children’s Hospital West Campus.

“Today, we’ve cut the ribbon on our second Purple Songs Can Fly recording studio,” said Purple Songs Can Fly Founder and Executive Director Anita Kruse. “We’ve had a studio at Main Campus since 2006 and now we’ve opened one at West Campus.”

Thanks to support from the Texas Commission on the Arts and the Children’s Fund, Kruse has been coming out to West Campus for two years with a portable recording studio, working with patients at their bedside, in clinic rooms or conference rooms to write and produce nearly 100 songs.

“This pilot project proved that a permanent recording studio would be a viable investment at West Campus, Kruse said. “The children were really excited about writing songs here. I feel that the studio and the songs that will be written at West Campus will bring a lot of joy to the families and the children who are here undergoing treatment.”

West Campus Texas Children’s Cancer and Hematology Centers Nurse Manager Judy Holloway said the transformation and the impact that Purple Songs Can Fly has on patients, families and staff is remarkable.

“We see miracles happen in the Cancer and Hematology Centers here at West Campus and this studio is a miracle in itself,” Holloway said. “A lot of our children are very sick. Having this available to them here at West Campus is a true blessing.”

Annalisa Cuano, a singer, songwriter and highly trained sound engineer, will manage the recording studio at West Campus. She has been working with Purple Songs Can Fly for two years at Main Campus and has recently spent a lot of her time at West Campus getting the studio ready for its official opening.

“The goal is to get these children out of their heads and able to share who they are and what they are going through in the purple space,” Cuano said. “It’s really incredible to watch. There’s some kind of self-fulfillment or self-validation when you give them their CD.”

Kruse said she is grateful to everyone at Texas Children’s who has helped make the West Campus studio become a reality and is thankful for the funds she received to build and staff the studio. Texas Children’s West Campus Child Life Department supported the build out of the space to prepare it for construction and grants from the Children’s Fund provided funding for the construction of the studio, paid for all of the equipment inside the studio and helped staff the studio for a year.

Carol Herron, coordinator of the Periwinkle Arts In Medicine Program, said she looks forward to hearing the music and seeing the smiles on the faces of the composers at the West Campus Purple Songs Can Fly studio.

“What you do makes a difference in the day of a child undergoing treatment of a serious disease,” Herron said to those involved in Purple Songs Can Fly. “Thank you for the gift you give to these families.”

The Texas Children’s Cancer and Hematology Centers recently held its 2017 Annual Advanced Practice Provider (APP) Education and Team Building Symposium.

The Cancer and Hematology Centers’ APP team consists of 25 APPs on 10 different disease teams.

The annual symposium provides an opportunity for professional development and collaboration across teams.

Presentations included:

  • Dr. Rona Sonabend on “Endocrinopathies in Children with Cancer”
  • Dr. Amanda Berger on “Pain and Pain Management in Children with Cancer”
  • Pat Wills Bagnato on “Mentorship Relationships”

There also was a teleconference call with the Association of Pediatric Hematology Oncology Nurses (APHON®) on their Mentorship Program.